435 (Metformin 850 mg)
Pill imprint 435 has been identified as Metformin hydrochloride 850 mg.
Metformin is used in the treatment of diabetes, type 2; polycystic ovary syndrome; insulin resistance syndrome; female infertility and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 850 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 435 (Metformin 850 mg)
- 850 mg
- 12.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC):
- Inactive Ingredients:
|NDC Code||Manufacturer / Repackager|
|63739-0300||McKesson Packaging Services|
|67544-0107||Prepak Systems Inc (repackager)|
|55887-0614||Diversified Healthcare Services Inc (repackager)|
|21695-0472||Rebel Distributors Corp (repackager)|
|55289-0934||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
Metformin hydrochloride is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...